Effects of charcoal, sodium bicarbonate, and ammonium chloride on chlorpropamide kinetics

scientific article published on 01 March 1983

Effects of charcoal, sodium bicarbonate, and ammonium chloride on chlorpropamide kinetics is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1038/CLPT.1983.50
P698PubMed publication ID6297841

P2093author name stringP. J. Neuvonen
S. Kärkkäinen
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectcharcoalQ177463
pharmacologyQ128406
chlorpropamideQ1075324
P304page(s)386-393
P577publication date1983-03-01
P1433published inClinical Pharmacology & TherapeuticsQ1101529
P1476titleEffects of charcoal, sodium bicarbonate, and ammonium chloride on chlorpropamide kinetics
P478volume33

Reverse relations

cites work (P2860)
Q40520287Antihyperglycaemic agents. Drug interactions of clinical importance
Q34480831Bench-to-bedside review: Antidotal treatment of sulfonylurea-induced hypoglycaemia with octreotide
Q67965763Chlorpropamide toxicity
Q40780201Features, prevention and management of acute overdose due to antidiabetic drugs
Q90537627Mechanistic PBPK Modeling of Urine pH Effect on Renal and Systemic Disposition of Methamphetamine and Amphetamine
Q39640378Oral activated charcoal in the treatment of intoxications. Role of single and repeated doses
Q70222704Oral hypoglycemic agents
Q38631248Pharmacokinetic-pharmacodynamic relationships of oral hypoglycaemic agents. An update
Q43445086Pharmacokinetics of chlorpropamide in epileptic patients: effects of enzyme induction and urine pH on chlorpropamide elimination
Q22305842Poisoning in the elderly. Epidemiological, clinical and management considerations
Q69669893Role of repeated oral doses of activated charcoal in clinical toxicology
Q38618657Sulphonylurea antidiabetic drugs. An update of their clinical pharmacology and rational therapeutic use.
Q42734557Sulphonylureas and hypoglycaemia
Q42007518The effect of cholestyramine and activated charcoal on glipizide absorption
Q39691344The influence of nutrition on the systemic availability of drugs. Part II: Drug metabolism and renal excretion
Q68658486The relationship between debrisoquine oxidation phenotype and the pharmacokinetics of chlorpropamide
Q39662366The relationship between the pharmacokinetics and pharmacodynamic effects of oral hypoglycaemic drugs
Q43062073Unwitnessed sulphonylurea poisoning in a healthy toddler

Search more.